Used primarily in research settings for its potent inhibition of the NLRP3 inflammasome, VX-765 demonstrates significant anti-inflammatory effects. It has been investigated for potential therapeutic applications in inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and type 2 diabetes due to its ability to reduce the production of pro-inflammatory cytokines like IL-1β. Additionally, studies explore its neuroprotective properties in models of traumatic brain injury, epilepsy, and neurodegenerative conditions including Alzheimer’s disease. Its role in suppressing caspase-1 activity makes it a valuable tool compound in understanding inflammasome-driven pathologies.